Debnath A, Mazumder R, Singh A, Singh R
PLoS One. 2025; 20(1):e0313830.
PMID: 39813224
PMC: 11734976.
DOI: 10.1371/journal.pone.0313830.
Rasul H, Ghafour D, Aziz B, Hassan B, Rashid T, Kivrak A
Appl Biochem Biotechnol. 2024; .
PMID: 39630336
DOI: 10.1007/s12010-024-05110-2.
Lee H, Emani P, Gerstein M
J Chem Inf Model. 2024; 64(23):8684-8704.
PMID: 39576762
PMC: 11632770.
DOI: 10.1021/acs.jcim.4c01116.
Cozzini P, Agosta F
Methods Mol Biol. 2024; 2834:171-180.
PMID: 39312165
DOI: 10.1007/978-1-0716-4003-6_8.
Wu Y, Liu F, Glenn I, Fonseca-Valencia K, Paris L, Xiong Y
J Med Chem. 2024; 67(18):16796-16806.
PMID: 39255340
PMC: 11890070.
DOI: 10.1021/acs.jmedchem.4c01632.
Building shape-focused pharmacophore models for effective docking screening.
Moyano-Gomez P, Lehtonen J, Pentikainen O, Postila P
J Cheminform. 2024; 16(1):97.
PMID: 39123240
PMC: 11312248.
DOI: 10.1186/s13321-024-00857-6.
Green synthesized extracts/Au complex of : Unrevealing the anti-cancer and anti-bacterial potentialities, supported by metabolomics and molecular modeling.
Aati S, Aati H, El-Shamy S, Khanfar M, A Naeim M, Hamed A
Heliyon. 2024; 10(13):e34000.
PMID: 39071630
PMC: 11283168.
DOI: 10.1016/j.heliyon.2024.e34000.
Identification of SARS-CoV-2 Mpro inhibitors through deep reinforcement learning for drug design and computational chemistry approaches.
Hazemann J, Kimmerlin T, Lange R, Mac Sweeney A, Bourquin G, Ritz D
RSC Med Chem. 2024; 15(6):2146-2159.
PMID: 38911172
PMC: 11187573.
DOI: 10.1039/d4md00106k.
Benchmarking different docking protocols for predicting the binding poses of ligands complexed with cyclooxygenase enzymes and screening chemical libraries.
Shamsian S, Sokouti B, Dastmalchi S
Bioimpacts. 2024; 14(2):29955.
PMID: 38505677
PMC: 10945300.
DOI: 10.34172/bi.2023.29955.
Integrating QSAR modelling and deep learning in drug discovery: the emergence of deep QSAR.
Tropsha A, Isayev O, Varnek A, Schneider G, Cherkasov A
Nat Rev Drug Discov. 2023; 23(2):141-155.
PMID: 38066301
DOI: 10.1038/s41573-023-00832-0.
A community effort in SARS-CoV-2 drug discovery.
Schimunek J, Seidl P, Elez K, Hempel T, Le T, Noe F
Mol Inform. 2023; 43(1):e202300262.
PMID: 37833243
PMC: 11299051.
DOI: 10.1002/minf.202300262.
ChemFlow_py: a flexible toolkit for docking and rescoring.
Monari L, Galentino K, Cecchini M
J Comput Aided Mol Des. 2023; 37(11):565-572.
PMID: 37620503
DOI: 10.1007/s10822-023-00527-z.
In Silico Structure-Based Vaccine Design.
Piplani S, Winkler D, Honda-Okubo Y, Khanna V, Petrovsky N
Methods Mol Biol. 2023; 2673:371-399.
PMID: 37258928
DOI: 10.1007/978-1-0716-3239-0_26.
Molecular Docking and Dynamics Simulation Studies Predict Potential Anti-ADAR2 Inhibitors: Implications for the Treatment of Cancer, Neurological, Immunological and Infectious Diseases.
Broni E, Striegel A, Ashley C, Sakyi P, Peracha S, Velazquez M
Int J Mol Sci. 2023; 24(7).
PMID: 37047766
PMC: 10095294.
DOI: 10.3390/ijms24076795.
Lessons Learnt from COVID-19: Computational Strategies for Facing Present and Future Pandemics.
Pavan M, Moro S
Int J Mol Sci. 2023; 24(5).
PMID: 36901832
PMC: 10003049.
DOI: 10.3390/ijms24054401.
MetaDOCK: A Combinatorial Molecular Docking Approach.
Kamal I, Chakrabarti S
ACS Omega. 2023; 8(6):5850-5860.
PMID: 36816658
PMC: 9933224.
DOI: 10.1021/acsomega.2c07619.
Towards Effective Consensus Scoring in Structure-Based Virtual Screening.
Nhat Phuong D, Flower D, Chattopadhyay S, Chattopadhyay A
Interdiscip Sci. 2022; 15(1):131-145.
PMID: 36550341
PMC: 9941253.
DOI: 10.1007/s12539-022-00546-8.
Assessing How Residual Errors of Scoring Functions Correlate to Ligand Structural Features.
Shulga D, Shaimardanov A, Ivanov N, Palyulin V
Int J Mol Sci. 2022; 23(23).
PMID: 36499344
PMC: 9739603.
DOI: 10.3390/ijms232315018.
Potent Alkaline Phosphatase Inhibitors, Pyrazolo-Oxothiazolidines: Synthesis, Biological Evaluation, Molecular Docking, and Kinetic Studies.
Hosseini Nasab N, Raza H, Shim R, Hassan M, Kloczkowski A, Kim S
Int J Mol Sci. 2022; 23(21).
PMID: 36362051
PMC: 9654533.
DOI: 10.3390/ijms232113262.
In Silico Investigations into the Selectivity of Psychoactive and New Psychoactive Substances in Monoamine Transporters.
Botha M, Kirton S
ACS Omega. 2022; 7(43):38311-38321.
PMID: 36340072
PMC: 9631908.
DOI: 10.1021/acsomega.2c02714.